Peptide Oligonucleotide CDMO Market Size, Share & Growth 2035

added blog Health

2026-10-21 10:11:05 -

The Global Peptide Oligonucleotide CDMO Market is experiencing remarkable expansion as pharmaceutical and biotechnology companies increasingly outsource complex drug development and manufacturing activities. The market is estimated to reach USD 3.6 billion in 2026 and is projected to grow to USD 12.4 billion by 2035, registering a compound annual growth rate (CAGR) of 14.7%. Rising...

0 Comments 0 Shares 329 Views 0 Reviews